Objective: We investigated changes in the endocannabinoid system and glucose metabolism during temporal lobe epileptogenesis. Methods: Because it is rarely possible to study epileptogenesis in humans, we applied the electrical amygdala kindling model in nonhuman primates to image Results: The seizure-onset zone exhibited an increased CB1R binding and a decreased glucose metabolism, which both aggravated gradually in extent and intensity throughout kindling. The ipsilateral thalamus and insula showed hypometabolism that coincided with an increase and a decrease in CB1R binding, respectively. These changes also became gradually more severe throughout kindling and overlapped with ictal perfusion changes during the final stage of amygdala kindling, with hyperperfusion in the ipsilateral thalamus and hypoperfusion in the ipsilateral insula. Significance: The observed changes in CB1R binding may reflect a combination of a protective mechanism of neurons against seizure activity that becomes stronger over time to combat more severe seizures, and on the other hand, a process of epileptogenesis that facilitates seizure activity and generalization, depending on the cell type involved in those specific regions. This study provides unique evidence that the CB1R is dynamically and progressively involved from the start of mesial temporal lobe epileptogenesis.
| INTRODUCTION
Epileptogenesis is not well understood and practically impossible to study in patients because patients' history before the first symptoms is frequently unknown. In contrast, the occurrence of epileptic seizures in the amygdala kindling animal model is highly controlled. In the rhesus monkey, seizure progression during amygdala kindling is slow, providing an ideal opportunity to study several systems believed to play a role in epileptogenesis longitudinally and within the same subjects. 1, 2 For centuries, cannabis has been used to treat epilepsy. 3 The endocannabinoid system (ECS) is a neuromodulatory system consisting of the cannabinoid receptors, the endocannabinoids (eCBs), and the mechanisms of their synthesis and degradation. Evidence of the role of the ECS in epilepsy is supported mainly by animal data and case studies, because very few clinical trials exist. 4, 5 In vitro and in vivo animal models of epilepsy have shown that cannabinoid agonists have anticonvulsant properties, and that the ECS plays a role in controlling excitability. [6] [7] [8] Studies with selective knock-out mice implied that the protective effect of the ECS is mediated by the type 1 cannabinoid receptor (CB1R) on the glutamatergic principal neurons. 8, 9 Functional imaging studies using 10 as a positron emission tomography (PET) radiotracer to study the CB1R, found an increase in CB1R binding in the seizure-onset zone (SOZ) and a decrease in the ipsilateral insula in patients with refractory mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE-HS). 11 The CB1R changes in the SOZ correlated negatively with the latency of the PET scan after a seizure, indicating that dynamic changes in CB1R availability occur in the chronic phase of this disorder. 11, 12 PET imaging of interictal cerebral glucose metabolism using fluorine-18-labeled fluorodeoxyglucose ([ 18 F]-FDG) is widely used in the presurgical workup of epilepsy patients.
N-[2-(3-cyano-phenyl)-3-(4-(2-[18F]fluoroethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide ([ 18 F]-MK-9470)
In patients with mTLE-HS, [
18 F]-FDG-PET imaging revealed interictal hypometabolism in the SOZ, hypometabolism in the frontal lobes, and a lesser degree of hypometabolism in the ipsilateral thalamus, basal ganglia, occipital and parietal lobes, and in the contralateral temporal lobe. 13, 14 In a previous study, we used the amygdala kindling model in rhesus monkeys to study longitudinal changes in ictal brain perfusion. 1 Here, we aimed to determine the possible role of the CB1R and its relation to brain glucose metabolism and ictal perfusion changes during temporal lobe epileptogenesis.
To that end, we assessed the course of interictal CB1R availability and cerebral glucose metabolism throughout amygdala kindling in the same animals using PET imaging.
| METHODS

| Animals
All experimental procedures were performed in accordance with EU Directive 2010/63/EU and were approved by the ethical committee at the KU Leuven. Eight male rhesus monkeys (Macaca mulatta, weighing 5.0-8.5 kg) participated in the experiments. Six monkeys were used to obtain baseline imaging values. Two monkeys underwent an amygdala kindling protocol, as described previously 1 and as summarized in the Appendix S1. We stimulated the amygdala in 358 sessions in Monkey S and 344 sessions in Monkey K. Both animals progressed from stage I seizures of short duration with minimal behavioral signs to stage IV seizures of longer duration and bilateral motor signs, as described by Wada and colleagues. 2 
| PET radiotracer synthesis
All radiotracers were prepared and labeled in-house. CB1R imaging was performed in all animals using the radioligand [
18 F]-MK-9470. 10 The precursor for tracer synthesis was obtained from Merck Research Labs (West Point, NY, USA), and labeling was performed using an alkylation with 2-[ 18 F]-fluoroethyl bromide as described previously. 10 The final product was obtained after high-performance liquid chromatography (HPLC) purification and had a radiochemical purity >95%. Specific activity was always higher than 90 GBq/lmol. The tracer was administered in a sterile solution of 5 mmol/L sodium acetate buffer pH 5.5 containing 6% of ethanol. 192 AE 20.1 MBq) for the baseline group vs the kindled monkeys, respectively. PET imaging was performed using an LSO-detector-based FOCUS 220 system (Siemens/Concorde Microsystems, Knoxville, TN), which has a nominal transaxial resolution of 1.35 mm full-width at half-maximum (FWHM). Data were acquired in a 128 9 128 9 95 matrix with a pixel width of 1.27 mm and a slice thickness of 0.8 mm. The coincidence window width was set at 6 ns. For quantification purposes, PET scans were reconstructed using an iterative maximum a posteriori probability algorithm, and scans were corrected for attenuation using a 86 Ge transmission source. 
| Volume of interest analysis
We used a volume of interest (VOI)-based analysis to evaluate the intersubject and test-retest variability in our group. Therefore, we constructed a VOI map consisting of 34 volumes (17 left and 17 right hemisphere) that were drawn manually on the segmented gray matter of the template MRI, 16 as described previously. 17, 18 The size of every VOI was at least 3 times the volumetric resolution of the PET camera in order to reduce partial volume effects. This VOI map was loaded on all parametric images to permit calculation of the average parametric values within each VOI (PMOD Inc., Zurich, Switzerland). The VOI map was adjusted based on the individual MR of the monkeys and transferred to all rigidly aligned functional scans. For each tracer, we calculated the test-retest value between the baseline and postimplantation scan of Monkey K and Monkey S, considering only the VOIs that were not affected by the implantation of the electrodes. The time between the 2 scans (≥5 weeks) was sufficient to rule out changes due to edema or subacute inflammation. The testretest variability for the radioligand parameter R i in VOI region i was determined as:
where the indices b and p refer to the baseline and postimplantation scan, respectively. To measure intersubject variability, we calculated the variation coefficient for each of the 34 VOIs as the SD/mean value over baseline measurements of all monkeys (N = 8).
| Z-score analysis
Because the number of subjects in each stage of the kindling group (n = 2) was insufficient to perform a sensitive voxel-based analysis with sufficient degrees of freedom, we calculated a z-score image for each scan in each kindling stage, as follows: z PET = (PET monkey_stageX -mean (PET controls ))/SD(PET controls ). Here PET monkey_stageX is the relative and smoothed (2.5 mm FWHM) PET image of Monkey K or Monkey S in each of the 4 clinical stages during kindling. The mean and SD are the mean and SD images across the relative and smoothed PET images of the control group. For each clinical stage, we calculated a binary conjunction image for the z-score images of Monkey K and Monkey S, representing the voxels that showed an increase or decrease in CB1R binding or glucose metabolism in both monkeys at a 1 and 2 SD threshold. These conjunction images were used for further analysis.
| Ictal [ 99m Tc]-ECD SPECT imaging
Ictal single-proton emission computed tomography (SPECT) perfusion imaging was performed using 99m-Technetium-labeled ethyl cysteinate diethylester ([ 99m Tc]-ECD) as radiotracer. A seizure was elicited by electrical stimulation of the amygdala 10 seconds after injection of the radiotracer while the monkey was awake. SPECT images were analyzed using the Subtraction Ictal SPECT co-registered to MRI (SISCOM) technique. 19 Details of this series of imaging experiments are described in Cleeren et al 1 and are summarized in the Appendix S1. (52%-73%) and test-retest variability (36%-63%). Because we were unable to estimate global changes due to this variability in the 2 experimental animals, we assessed regional changes by relative scaling to the global mean brain uptake. For this regional mean relative uptake, intersubject and test-retest variability for both tracers are listed in Table 1 . There were no formal outlier values in the relative VOI values for the baseline monkeys for each radiotracer.
Intersubject variability of the relative regional CB1R binding ranged from 2.42% (contralateral cerebellum) to 15.98% (ipsilateral globus pallidus) ( 
| Changes in the interictal relative regional CB1R binding during amygdala kindling
The conjunction of the z-score images of the relative regional changes thresholded at 1 and 2 SD of both kindled monkeys is depicted in Figure 1 , overlaid on the MRI of Monkey S. Amygdala kindling induced widespread significant changes in CB1R binding in every clinical stage. An increased CB1R binding was observed bilaterally in the mesial temporal lobe (mainly in stage II; white arrows in Figure 1 ), thalamus (orange arrows in Figure 1 ), cerebellum, parietal, and occipital cortex, and ipsilaterally in the caudate nucleus and contralaterally in the insula. The largest cluster of increased CB1R binding was seen in the ipsilateral limbic temporal lobe, extending to the thalamus. When applying the anatomical VOI of the limbic temporal lobe to these conjunction images (thresholded at 1 SD), we observed that the number of voxels that showed an increased CB1R binding ipsilaterally peaked in stage II, but was still 3 times higher in stage IV as compared to stage I (Figure 2A) . Furthermore, the increase in CB1R binding became lateralized to the site of seizure onset in stage IV. The intensity of the increased binding also rose gradually in the ipsilateral limbic temporal lobe (Figure 2B ). Within the anatomical VOI of the thalamus, the number of voxels with an increased CB1R level grew gradually over the different stages of amygdala kindling in the ipsilateral hemisphere ( Figure 2C ). The mean z-score within the thalamus was about 3 times higher in stage IV compared to stage I, but peaked in stage II ( Figure 2D ). We also observed decreases in CB1R binding throughout the amygdala kindling process in, for example, the ipsilateral insula (cyan arrows in Figure 1 ) and lateral temporal | 963 lobe and bilaterally in the putamen, and (pre)frontal, motor, and somatosensory cortex (Figure 1 ). The ipsilateral insula contained an increasing number of voxels showing a downregulation of the CB1R throughout the kindling process ( Figure 2E ) and became lateralized to the ipsilateral hemisphere from stage II on. The mean z-score in this anatomical VOI showed a small upregulation of the CB1R in stage I, but a gradual decrease thereafter over time reaching a mean z-score of À0.31 in stage IV ( Figure 2F ).
3.3 | Changes in interictal relative glucose metabolism during the amygdala kindling Figure 3 illustrates the conjunction of the [ 18 F]-FDG zscore images of the 2 kindled subjects in the different clinical stages at the 1 SD and 2 SD thresholds. Throughout kindling, we observed a widespread bilateral decrease in brain glucose metabolism. The largest cluster of hypometabolism was seen in the insula and in the lateral temporal cortex ipsilateral to the kindling stimulation site during stage IV seizures (white circles in Figure 3 ). Other areas showing hypometabolism included the ipsilateral (orbito) frontal cortex, the putamen, the contralateral motor cortex, I, ipsilateral from the kindling site; C, contralateral from the kindling site; cc, cubic centimeters; NA, not applicable, test-retest could not be calculated between baseline and postoperative scans in those VOIs that were affected by electrode implantations (note that Monkey K had bilateral implanted electrodes and the ones in the left hemisphere were not working).
F I G U R E 1 Interictal changes in CB1R binding as measured with [
18 F]-MK-9470. This figure depicts the conjunction image of the z-score images of Monkey K and Monkey S. Z-score images were thresholded at either 1 SD with respect to the control group, where red depicts an increase and blue a decrease in CB1R binding, or at 2 SD, where orange depicts an increase and cyan a decrease in CB1R binding. The different rows illustrate the different clinical stages during amygdala kindling. Coronal slices are shown in radiological convention. The orange and white arrows depict an increase of CB1R binding in the thalamus and mesial temporal lobe bilaterally, respectively. In fact, these 2 areas are part of 1 large cluster of increased CB1R binding, which is further extending to parietooccipital areas. A decrease in CB1R binding was observed in for example, the ipsilateral insula, as marked with a cyan arrow the posterior insula, the caudate, the cerebellum, and the thalamus bilaterally (orange arrows in Figure 3 ). We also observed few areas that showed an increase in glucose metabolism over the course of kindling: ipsilaterally in the cingulate cortex and mesial temporal lobe, contralaterally in the posterior hippocampus, and bilaterally in the somatosensory cortex and early visual areas. These clusters of hypermetabolism seemed to be less consistent over clinical kindling stages.
The most striking area of hypometabolism in stage IV of kindling was the ipsilateral insula and temporal lobe. Figure 4A and B show the progression of the number of hypometabolic voxels in the anatomical VOIs of these areas at the 1 SD threshold. Both areas were hypometabolic from stage I on, but the number of the hypometabolic voxels increased gradually during the course of kindling. Lateralization of this hypometabolism was most apparent from stage III. In addition to an increase in the extent of the hypometabolic cluster, we also observed that the mean z-score within these VOIs became more hypometabolic ( Figure 4D ,E). Another area with consistent hypometabolism was the thalamus (Figures 3 and 4C) . The mean z-score of the ipsilateral thalamus decreased throughout the 4 stages of kindling ( Figure 4F ). The average increase in metabolism during stage I in the ipsilateral thalamus ( Figure 4F ) seems contradictory with the decrease shown in Figure 3 . However, because the anatomical VOI of the thalamus is larger than the thresholded changes displayed in Figure 3 , this effect is likely diluted over this whole volume. Note that we observed hypometabolism in the lateral temporal cortex, not in the amygdala itself. 
| Joint changes in interictal CB1R
binding, glucose metabolism, and ictal perfusion The brain areas that are involved during an epileptic seizure can be imaged by ictal brain perfusion imaging using [ 99m Tc]-ECD SPECT imaging. Both kindled monkeys were subjected to ictal brain perfusion imaging throughout the kindling process, as described earlier. 1 Here, we compared the conjunction of this ictal perfusion network of both monkeys (at 1 SD) with the results of the PET experiments. During stage IV, 3 clusters survived the 3-fold conjunction (changes in perfusion, CB1R binding, and metabolism at 1 SD; minimum cluster size 50 voxels). The ipsilateral thalamus showed a combined ictal hyperperfusion and interictal hypometabolism and increased CB1R binding. The ipsilateral insula showed a decrease in ictal perfusion, interictal metabolism, and CB1R binding. In the contralateral premotor cortex, we found a cluster of ictal hyperperfusion, and a decrease in both interictal metabolism and CB1R binding. In the early kindling stages, we observed only one cluster showing ictal hyperperfusion, interictal hypometabolism, and a decreased CB1R binding in the ipsilateral orbitofrontal cortex during stage II.
| DISCUSSION
We investigated changes in interictal metabolism and cannabinoid type 1 receptor expression in a nonhuman primate model of temporal lobe epileptogenesis. During amygdala kindling, the monkeys presented with evoked seizures, arising from the right amygdala, that slowly increased in duration and semiology. 1, 2 It is this progressive nature, among other reasons, that makes this model valid and interesting for studying temporal lobe epileptogenesis. In every stage of the model, we quantified interictal metabolism and CB1R binding using PET imaging. We found widespread changes in metabolism and CB1R binding, many of which were consistent over time, which is in agreement with the results of our ictal SPECT experiments in nonhuman primates in which we described a common network of perfusion changes.
1 Type 1 cannabinoid receptors are expressed both on glutamatergic excitatory and GABAergic (gamma-aminobutyric acid) inhibitory neurons. This means that the ECS reduces overactive neurotransmission of both excitatory and inhibitory neurotransmitters. In patients, CB1R availability causes opposite changes in different brain regions involved in temporal lobe seizures, 11, 12 which is most likely due to cell-type-specific modifications. However, in patients it is impossible to study functional changes early during epileptogenesis. Therefore, we imaged longitudinal changes, starting from a naive brain, in CB1R availability during induced temporal lobe epileptogenesis in an animal model. Remarkably, we observed changes in CB1R availability in the earliest stage of kindling. CB1R availability in the SOZ (right amygdala) and the ipsilateral thalamus increased from stage I on and remained elevated. Moreover, this CB1R upregulation gradually increased throughout kindling. In contrast, previous studies in rodents showed that CB1Rs are F I G U R E 4 Changes in metabolism in the temporal lobe, insula, and thalamus. Bar plots showing the progression of the number of hypometabolic voxels in the different clinical stages of amygdala kindling in the anatomical VOI of the temporal lobe (A), insula (B), and thalamus (C). D, E, F, Progression of the mean z-score in these anatomical VOIs. The mean z-score is calculated as the mean z-score of the nonthresholded z-score image in these VOIs, averaged over both kindled monkeys. In every panel, blue bars indicate the ipsilateral VOIs, while the orange bars indicate the contralateral VOIs downregulated in the SOZ in the acute phase of an epilepsy model but upregulated in the chronic phase. [20] [21] [22] In the ipsilateral insula, the number of voxels showing a decreased CB1R availability was gradually growing throughout kindling. Although PET imaging allows for in vivo imaging of the CB1R in behaving animals, it cannot distinguish between the different subpopulations of neurons on which these receptors are present. Therefore, our observed gradual upregulation of the CB1R in the SOZ and the ipsilateral thalamus and the gradual downregulation in the ipsilateral insula can be interpreted in several ways. First, it may reflect an antiepileptic and neuroprotective mechanism, which can be an acute effect by activation of CB1Rs on glutamatergic neurons, leading to reduced excitability. During seizures, axon terminals release an excessive amount of glutamate, which will activate the receptor-driven 2-AG (2-arachidonoyl glycerol, an endocannabinoid) synthesis pathway. 12 This will activate the CB1R, suppress glutamate release, and prevent the overexcited circuits from undergoing uncontrolled hyperexcitability. 12 That way, an eCB-mediated negative feedback control system is activated. Indeed, the levels of eCBs were elevated after acute insults. 8, 22, 23 In addition, administering a CB1R agonist had anticonvulsant effects in several animal models by increasing the eCB concentration. 6, 7 In our previous studies 1, 17 we reported that the ipsilateral thalamus shows ictal hyperperfusion and is effectively connected to the kindled amygdala, indicating that seizure activity reaches the thalamus fast. Therefore, the same mechanism of acute protection against hyperexcitability could have taken place in the thalamus. As seizures became more severe, this protection mechanism should become stronger, leading to an increasing upregulation of the CB1R on glutamatergic terminals over time. Neuroprotection can also be the result of a long-term downregulation of the CB1R on GABAergic neurons, which will lead to an increased inhibition, thereby contributing to the prevention of seizure propagation. Second, gradual changes in the CB1R levels could reflect a proepileptic effect. A decreased CB1R availability on glutamatergic neurons results in a decrease of depolarization induced suppression of excitation (DSE), yielding hyperexcitable neurons. The eCB-mediated negative feedback control system could be functionally compromised in chronic epilepsy. 24 Moreover, administration of an indirect CB1R agonist can delay kindling progression through principal glutamatergic neurons in rats. 25 In addition, our data suggest that the "failure" of this control system became apparent early during epileptogenesis. According to this interpretation, this control system will no longer be able to prevent the generation and generalization of seizures. 12 In addition, a long-term upregulation of CB1Rs on GABAergic neurons promotes seizure activity by an increased suppression of inhibition, which renders neurons more excitable. Indeed, in the hippocampi of patients with epilepsy, CB1R expression on inhibitory axon terminals was upregulated. 26 The gradual rise of CB1R availability on GABAergic neurons during epileptogenesis could therefore be responsible for creating a hyperexcitable network in which seizure activity can be aggravated and spread. Third, and most likely, upregulation of CB1Rs could reflect a combination of the previous 2 phenomena. In any case, it is clear that progressive changes in CB1R availability took place throughout the brain during mesial temporal lobe epileptogenesis and that these changes already occurred at the earliest stage. Therefore, an early intervention targeted at the cell-specific CB1R to avoid repeated seizures should be a desirable goal to prevent a kindlinglike phenomenon in patients.
Interictal [
18 F]-FDG-PET imaging in our animal model revealed similar changes during stage IV of amygdala kindling as compared to patients with mTLE-HS. 14 In contrast to patient studies, we studied the metabolic changes longitudinally starting from the naive brain and reported early and gradual increases in relative hypometabolism in the ipsilateral temporal lobe, insula, and thalamus. In addition to relative changes in CB1R availability and metabolism in and around the SOZ, the ipsilateral mediodorsal thalamus and the insula seemed to be the key nodes of the epileptogenic network. During stage IV, in which the animals experienced secondarily generalized seizures, these interictal changes also overlapped with the ictal perfusion changes seen during SPECT imaging. The insula lies between the temporal and frontal lobes, which showed hyperperfusion and hypoperfusion, respectively, both during complex partial seizures in patients 27 and in our subjects. 1 Furthermore, the amygdala has dense connections to the insula, 28 as confirmed by electrical microstimulation during functional MRI (EM-fMRI) in our subjects. 17 Seizure activity originating in the temporal lobe often spreads to the insular cortex. 29 In the insular cortex, CB1Rs are expressed in moderate levels (in humans 30 ) and are mainly present on GABAergic nerve terminals (in rats 31 ). A decreased level of CB1Rs on these nerve terminals may thus result in an increased level of inhibition, which might contribute to prevention of seizure propagation. This reduced CB1R availability coincided with ictal hypoperfusion and interictal hypometabolism. We therefore hypothesize that this growing CB1R decrease could reflect surround inhibition, 32 which is in accordance with previous studies.
11 ,14,27 Our baseline group had a high intersubject variability for both tracers. The range of test-retest and intersubject variability for relative [ 18 F]-FDG values was comparable to that for rodent studies. 33 Because there are known interspecies differences in CB1R expression, 34 the normal distribution and variation for a specific radiotracer targeting the CB1R should be considered species-specific. may still be considered a postictal scan that could be different from a scan obtained days or weeks after a seizure, as is generally done in clinical practice. We applied this time interval for several practical and logistical reasons (clinical tracer production schedules and use of sedatives with potential antiepileptic effects). Furthermore, we believe that tracer injection was always truly interictal in our subjects because electroclinical findings in our subjects pointed to a postictal period of maximum 75 seconds. Because of our small number of subjects, we calculated the conjunction of the changes seen in both monkeys, and we are thus displaying only those changes that are similar in both subjects. This might be more stringent than calculating group averages, while neglecting possible subtle alterations. Data on receptor functioning, signal transduction, and activation by eCBs are lacking and beyond the scope of our study. If we want to draw solid conclusions regarding therapies that tackle the ECS, information on receptor distributions alone are not sufficient. G-proteincoupled receptors, like the CB1R, are assumed to act in a compensatory manner to the endogenous ligand concentrations. In the pilocarpine model of epilepsy, for example, increased levels of hippocampal 2-AG were measured during status epilepticus. 22 However, in the cerebrospinal fluid (CSF) of drug-naive patients with TLE, the levels of anandamide, but not 2-AG was reduced. 35 Some studies found CB1R desensitization and internalization following chronic tetrahydrocannabinol (THC) treatment 36 ; others observed an increase in CB1R density after chronic exposure to THC and anandamide. 37 Furthermore, it was reported that a large CB1R reserve is located in intracellular vesicles. 38 It is unknown whether [ 18 F]-MK-9470 binds to these intracellular CB1Rs. Future studies applying microdialysis in a target area would deliver useful information about synaptic activity. The role of cannabis compounds for the treatment of epilepsy is currently receiving attention, with a special focus on cannabidiol. However, the effects in patients with different types of pharmacoresistant epilepsy, especially mTLE, are not conclusive. It was shown that some effects of cannabidiol are effectuated by an indirect effect on the CB1R. 39, 40 From our data, we speculate that a nonspecific cannabinoid drug could have different and possibly opposing effects within different parts of the epileptic network, which appears to be a major challenge for the development of eCB signaling system-based treatments for epilepsy. 12 This study provides unique evidence that the ECS and more specifically the CB1R, is involved in the epileptogenesis of mTLE at a very early stage and becomes gradually more involved as seizure severity increases, resulting in chronic changes in CB1R availability. Use of an animal model has the advantage of starting from a naive brain and can therefore document a causal relationship between epileptogenesis and changes in the ECS, in contrast to patient studies, which show correlational changes in a chronic stage. Our results during the final stage of kindling were comparable with the changes seen in patients with chronic mTLE-HS, providing further support for the validity of the amygdala kindling model in rhesus monkeys for the study of temporal lobe epileptogenesis. Specifically targeted interactions with the ECS early during epileptogenesis could, therefore, be beneficial for the prevention of a kindling-like increase in seizure severity in patients.
